Drug discovery, drug resistance
Cynthia Hajal
Northeastern University / prev. Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Simona Dalin
Dana-Farber Cancer Institute
Boston, United States
Greg Raskind
Dana-Farber Cancer Institute
Boston, United States
Margaret Cusick
Dana-Farber Cancer Institute
Boston, United States
Seth Malinowski, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jakob Ito
German Cancer Research Center
Heidelberg, Baden-Wurttemberg, Germany
Connor Bossi
Dana-Farber Cancer Institute
Boston, United States
Jayne Vogelzang
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Charlotte Bellamy
Paris Brain Institute
Paris, Ile-de-France, France
Lisa Salhi
Paris Brain Institute (ICM)
Paris, France
Franck Bielle
Pitie Salpetriere Hospital
Paris, Ile-de-France, France
Gad Getz
Broad Institute of MIT and Harvard
Cambridge, Massachusetts, United States
Pratiti Bandopadhayay
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Mehdi Touat
Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) Sorbonne Université
Paris, Massachusetts, France
Rameen Beroukhim
Center for Neuro-Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Keith L. Ligon
Brigham and Women's Hospital
Boston, Massachusetts, United States